Controlled delivery of antibodies from injectable hydrogels
- 1 February 2016
- journal article
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 59, 801-806
Abstract
No abstract availableKeywords
Funding Information
- Boettcher Foundation (11219)
- Colorado Office of Economic Development and International Trade (13BGF-22)
This publication has 16 references indexed in Scilit:
- Hyaluronic acid hydrogel modified with nogo‐66 receptor antibody and poly‐L‐lysine to promote axon regrowth after spinal cord injuryJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2010
- Development trends for therapeutic antibody fragmentsNature Biotechnology, 2009
- Polyelectrolyte complex formation using alginate and chitosanCarbohydrate Polymers, 2008
- An experimental test of stroke recovery by implanting a hyaluronic acid hydrogel carrying a Nogo receptor antibody in a rat modelBiomedical Materials, 2007
- Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheresInternational Journal of Pharmaceutics, 2007
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Hyaluronic acid hydrogel as Nogo-66 receptor antibody delivery system for the repairing of injured rat brain: in vitroJournal of Controlled Release, 2005
- Controlled-release and local delivery of therapeutic antibodiesExpert Opinion on Biological Therapy, 2004
- Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheresJournal of Controlled Release, 1997
- Controlled delivery of antibodies against leukocyte adhesion molecules from polymer matricesJournal of Controlled Release, 1996